Corsair Capital Management L.P. Makes New $298,000 Investment in Rockwell Medical, Inc. (NASDAQ:RMTI)

by · The Cerbat Gem

Corsair Capital Management L.P. acquired a new position in shares of Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 75,000 shares of the company’s stock, valued at approximately $298,000. Corsair Capital Management L.P. owned 0.24% of Rockwell Medical as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Concurrent Investment Advisors LLC acquired a new stake in Rockwell Medical in the third quarter worth $40,000. Verus Capital Partners LLC acquired a new stake in shares of Rockwell Medical in the 3rd quarter valued at about $51,000. Beacon Financial Advisory LLC bought a new stake in Rockwell Medical in the 3rd quarter valued at about $98,000. Vanguard Group Inc. raised its stake in Rockwell Medical by 4.0% during the 1st quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock worth $1,856,000 after buying an additional 43,302 shares during the period. Finally, Renaissance Technologies LLC boosted its holdings in Rockwell Medical by 877.1% in the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after acquiring an additional 92,189 shares in the last quarter. Institutional investors own 23.31% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on RMTI shares. StockNews.com downgraded Rockwell Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. HC Wainwright decreased their target price on shares of Rockwell Medical from $9.00 to $7.00 and set a “buy” rating for the company in a research report on Monday. RODMAN&RENSHAW upgraded Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. Finally, Rodman & Renshaw started coverage on Rockwell Medical in a report on Thursday, November 14th. They issued a “buy” rating and a $5.00 target price on the stock.

Get Our Latest Research Report on Rockwell Medical

Rockwell Medical Stock Down 2.6 %

RMTI stock opened at $2.25 on Wednesday. The stock’s fifty day simple moving average is $3.46 and its two-hundred day simple moving average is $2.66. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. The stock has a market cap of $72.72 million, a P/E ratio of -45.00 and a beta of 1.50. Rockwell Medical, Inc. has a 1-year low of $1.16 and a 1-year high of $5.15.

Rockwell Medical Profile

(Free Report)

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.

Featured Articles

Want to see what other hedge funds are holding RMTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report).